BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23771734)

  • 1. Causes of CNS inflammation and potential targets for anticonvulsants.
    Falip M; Salas-Puig X; Cara C
    CNS Drugs; 2013 Aug; 27(8):611-23. PubMed ID: 23771734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.
    Dey A; Kang X; Qiu J; Du Y; Jiang J
    Trends Pharmacol Sci; 2016 Jun; 37(6):463-484. PubMed ID: 27062228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.
    Dambach H; Hinkerohe D; Prochnow N; Stienen MN; Moinfar Z; Haase CG; Hufnagel A; Faustmann PM
    Epilepsia; 2014 Jan; 55(1):184-92. PubMed ID: 24299259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target.
    Mukhtar I
    Seizure; 2020 Nov; 82():65-79. PubMed ID: 33011590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.
    Maroso M; Balosso S; Ravizza T; Liu J; Aronica E; Iyer AM; Rossetti C; Molteni M; Casalgrandi M; Manfredi AA; Bianchi ME; Vezzani A
    Nat Med; 2010 Apr; 16(4):413-9. PubMed ID: 20348922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1.
    Maroso M; Balosso S; Ravizza T; Liu J; Bianchi ME; Vezzani A
    J Intern Med; 2011 Oct; 270(4):319-26. PubMed ID: 21793950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy.
    Vezzani A; Balosso S; Maroso M; Zardoni D; Noé F; Ravizza T
    Curr Opin Investig Drugs; 2010 Jan; 11(1):43-50. PubMed ID: 20047158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
    Vezzani A
    Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokines and the nervous system: the relationship between seizures and epilepsy].
    Velasco-Ramirez SF; Rosales-Rivera LY; Ramirez-Anguiano AC; Bitzer-Quintero OK
    Rev Neurol; 2013 Aug; 57(4):171-7. PubMed ID: 23884872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glia and epilepsy: excitability and inflammation.
    Devinsky O; Vezzani A; Najjar S; De Lanerolle NC; Rogawski MA
    Trends Neurosci; 2013 Mar; 36(3):174-84. PubMed ID: 23298414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.
    Alyu F; Dikmen M
    Acta Neuropsychiatr; 2017 Feb; 29(1):1-16. PubMed ID: 27692004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain inflammation in epilepsy: experimental and clinical evidence.
    Vezzani A; Granata T
    Epilepsia; 2005 Nov; 46(11):1724-43. PubMed ID: 16302852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.
    Vitaliti G; Pavone P; Mahmood F; Nunnari G; Falsaperla R
    Hum Vaccin Immunother; 2014; 10(4):868-75. PubMed ID: 24609096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
    Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
    Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies.
    van Vliet EA; Aronica E; Vezzani A; Ravizza T
    Neuropathol Appl Neurobiol; 2018 Feb; 44(1):91-111. PubMed ID: 28977690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage.
    Librizzi L; Noè F; Vezzani A; de Curtis M; Ravizza T
    Ann Neurol; 2012 Jul; 72(1):82-90. PubMed ID: 22829270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures in autoimmune encephalitis: Kindling the fire.
    Wesselingh R; Butzkueven H; Buzzard K; Tarlinton D; O'Brien TJ; Monif M
    Epilepsia; 2020 Jun; 61(6):1033-1044. PubMed ID: 32400012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 in epilepsy.
    Rojas A; Jiang J; Ganesh T; Yang MS; Lelutiu N; Gueorguieva P; Dingledine R
    Epilepsia; 2014 Jan; 55(1):17-25. PubMed ID: 24446952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.